SIETES :: 92427 citas

Resultados de la búsqueda por ANALGÉSICOS REFINAR BÚSQUEDA

1.

Anónimo. CDC says multiple doses of naloxone needed for overdoses linked to fentanyl. DIA Daily 2018:8. [Ref.ID 102713]

2.

McGreal C. La justicia suspende en Nevada una ejecución con fentanilo, la droga en el centro de la epidemia de opiáceos. eldiario.es 2018:11 de julio. [Ref.ID 102706]

3.

Anónimo. Study shows that nearly half of overdose deaths are from fentanyl. DIA Daily 2018:3. [Ref.ID 102704]

4.

Hadland SE, Cerdá M, Li Y, Krieger MS, Marshall BDL. Association of pharmaceutical industry marketing of opioid products to physicians with subsequent opioid prescribing. JAMA Intern Med 2018:14 de mayo. [Ref.ID 102637]

5.

Anónimo. Flupirtine: Serious liver problems. European Union. WHO Drug Information 2018;32:21. [Ref.ID 102625]

6.

Salm-Reifferscheidt L. Tramadol: Africa's opioid crisis. Lancet 2018;391:19 de mayo. [Ref.ID 102613]

7.

Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]

8.

Wiese AD, Griffin MR, Schaffner W, Stein CM, Greevy RA, Mitchel Jr EF, Grijalva CG. Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study. Ann Intern Med 2018;168:20 de marzo. [Ref.ID 102563]

9.

Lembke A, Papac J, Humphreys K. Our other prescription drug problem. N Engl J Med 2018;378:22 de febrero. [Ref.ID 102557]

10.

Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, Kroenke K, Bair MJ, Noorbaloochi S. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee ostoarthritis pain. The SPACE randomized clinical trial. JAMA 2018;319:6 de marzo. [Ref.ID 102554]

11.

Peckham AM, Fairman KA, Sclar DA. All-cause and drug-related medical events associated with overuse of gabapentin and/or opioid medications: a retrospective cohort analysis of a commercially insured US population. Drug Saf 2018;41:213-28. [Ref.ID 102542]

12.

Anónimo. Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse. FDA U.S. Food and Drug Administration 2018:6 de febrero. [Ref.ID 102525]

13.

Anónimo. Opioid prescriptions fell 10 percent last year, report says . DIA Daily 2018:13. [Ref.ID 102519]

14.

Herzig SJ, Mosher HJ, Calcaterra SL, Jena AB, Nuckols TK. Improving the safety of opioid use for acute noncancer pain in hospitalized adults: a consensus statement from the Society of Hospital Medicine. J Hosp Med 2018;13:abril. [Ref.ID 102501]

15.

Joseph A. In rare advisory, surgeon general urges public to carry overdose-reversal medication. STAT Daily Recap 2018:5. [Ref.ID 102500]

16.

Novoa A. Las estrategias comerciales de la industria farmacéutica, matan: el caso de los opioides en EE.UU. NoGracias 2018:1. [Ref.ID 102497]

17.

Olfson M, Wall MM, Liu SM, Blanco C. Cannabis use and risk of prescription opioid use disorder in the United States. Am J Psychiatry 2018;175:enero. [Ref.ID 102495]

18.

Wen H, Hockenberry JM. Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees . JAMA Intern Med 2018:2 de abril. [Ref.ID 102494]

19.

Bradford AC, Bradford WD, Abraham A, Bagwell Adams G. Association between US state medical cannabis laws and opioid prescribing in the Medicare Part D population. JAMA Intern Med 2018:2 de abril. [Ref.ID 102493]

20.

Hill KP, Saxon AJ. The role of cannabis legalization in the opioid crisis. JAMA Intern Med 2018:2 de abril. [Ref.ID 102492]